- Home
- ONCY vs ITRM Comparison
ONCY vs ITRM Comparison
Compare ONCY & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- ITRM
- Stock Information
- Founded
- ONCY 1998
- ITRM 2015
- Country
- ONCY Canada
- ITRM Ireland
- Employees
- ONCY N/A
- ITRM N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- ITRM Health Care
- Exchange
- ONCY Nasdaq
- ITRM Nasdaq
- Market Cap
- ONCY 53.6M
- ITRM N/A
- IPO Year
- ONCY 1999
- ITRM 2018
- Fundamental
- Price
- ONCY $0.56
- ITRM $1.25
- Analyst Decision
- ONCY Strong Buy
- ITRM Strong Buy
- Analyst Count
- ONCY 4
- ITRM 1
- Target Price
- ONCY $4.00
- ITRM $5.00
- AVG Volume (30 Days)
- ONCY 224.8K
- ITRM 267.7K
- Earning Date
- ONCY 03-07-2025
- ITRM 05-12-2025
- Dividend Yield
- ONCY N/A
- ITRM N/A
- EPS Growth
- ONCY N/A
- ITRM N/A
- EPS
- ONCY N/A
- ITRM N/A
- Revenue
- ONCY N/A
- ITRM N/A
- Revenue This Year
- ONCY N/A
- ITRM N/A
- Revenue Next Year
- ONCY N/A
- ITRM $160.88
- P/E Ratio
- ONCY N/A
- ITRM N/A
- Revenue Growth
- ONCY N/A
- ITRM N/A
- 52 Week Low
- ONCY $0.55
- ITRM $0.81
- 52 Week High
- ONCY $1.53
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- ONCY 27.91
- ITRM 33.48
- Support Level
- ONCY $0.58
- ITRM $1.37
- Resistance Level
- ONCY $0.65
- ITRM $1.50
- Average True Range (ATR)
- ONCY 0.03
- ITRM 0.07
- MACD
- ONCY -0.00
- ITRM -0.01
- Stochastic Oscillator
- ONCY 1.34
- ITRM 13.33
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.